ArticleInternational medical case reports journal2017

Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report.

Elisabetta Gambale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.